Nyxoah (NASDAQ:NYXH) and Rennova Health (OTCMKTS:RNVA) Head-To-Head Contrast

Nyxoah (NASDAQ:NYXH) and Rennova Health (OTCMKTS:RNVA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for Nyxoah and Rennova Health, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1	0	3	1	2.80
Rennova Health	0	0	0	0	0.00

Nyxoah presently has a consensus price target of $11.33, indicating a potential upside of 267.97%. Given Nyxoah’s stronger consensus rating and higher probable upside, equities analysts plainly believe Nyxoah is more favorable than Rennova Health.

Valuation and Earnings

This table compares Nyxoah and Rennova Health”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33 million	10.54	-$101.92 million	($2.68)	-1.15
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A

Rennova Health has higher revenue and earnings than Nyxoah.

Risk & Volatility

Nyxoah has a beta of 1.56, meaning that its share price is 56% more volatile than the S&P 500. Comparatively, Rennova Health has a beta of 22.87, meaning that its share price is 2,187% more volatile than the S&P 500.

Profitability

This table compares Nyxoah and Rennova Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nyxoah	-884.69%	-139.18%	-79.53%
Rennova Health	N/A	N/A	N/A

Summary

Rennova Health beats Nyxoah on 6 of the 10 factors compared between the two stocks.

About Nyxoah

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.